A win-win situation: How optimising medication management delivers for patients, taxpayers and the UK health system


Publish date: Dec 11, 2023

There is a significant opportunity for improvement and transformation in the UK health system to address the current slow and piecemeal approach to the adoption of innovative medicines management technology. Connected Medication Management (CMM) technology has the potential to transform every step of the medicines pathway, from supply through to the patient bedside – it can help create a safer, smarter, and more efficient health system. While there is some adoption of this technology across the UK, its full potential to tackle the UK health system’s biggest challenges is not widely understood and as such, it not been an area of focus for national policy and decision makers in government and the NHS. The aim of this CMM Policy Vision is to discuss the benefits of CMM technology and bring to life how strategic deployment can deliver for patients, taxpayers, and the UK health system. 

The complete CMM Policy Vision paper can be found and downloaded here.


The CMM Policy Vision paper considers:

  • Relieving workforce pressures by releasing time for high-value tasks
  • Driving financial savings through smart management of medicines
  • Building a safer health system by reducing prevalence of medication errors
  • The Impact of Connected Medication Management on the system


Should you want further information regarding Connected medication management please sign up here  


Should you require further information on the Connected medication management policy please contact; 

Patrick Wilkinson, Marketing Manager, Connected Medication Management | 07912 552943 

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.



Troy Kirkpatrick

858 617 2361

Email Troy